News Technology Bristol Myers Squibb (BMY) Announces EMA Validates its Application for Opdivo as Adjuvant Remedy for Resected Esophageal or Gastroesophageal Junction Cancer Adhering to Chemoradiotherapy By FeliciaF.Rose 5 years ago …
